Nektar completes sale of Huntsville manufacturing facility to Ampersand affiliate

NEKTAR THERAPEUTICS

Closed disposition of Huntsville, AL manufacturing facility and related assets to an affiliate of Ampersand Capital Partners.
Transaction completed on December 2, 2024, as previously announced on November 4, 2024.
Purchaser assumed certain related liabilities; no financial terms disclosed in the filing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.